Carbon ion radiotherapy eradicates medulloblastomas with chromothripsis in an orthotopic Li-Fraumeni patient-derived mouse model

Keyphrases

• Chromothripsis 100%
• Mouse Model 100%
• Medulloblastoma 100%
• Li-Fraumeni 100%
• Carbon Ion Radiotherapy 100%
• Carbon Ions 100%
• Patient-derived 100%
• Tumor 60%
• PARP Inhibitors (PARPi) 60%
• Neurogenesis 40%
• Postoperative Radiotherapy 40%
• Radiotherapy 20%
• Chemotherapy 20%
• Whole Genome Sequencing 20%
• Patient-derived Xenograft 20%
• Li-Fraumeni Syndrome 20%
• Histology 20%
• Dismal Prognosis 20%
• Vulnerability 20%
• Nave 20%
• Molecular Characterization 20%
• Topotecan 20%
• Brain Tumor 20%
• Clonal Composition 20%
• DNA Repair 20%
• Major Change 20%
• Tumor Model 20%
• Median Survival 20%
• Photon Radiotherapy 20%
• Relapsed Patients 20%
• Post-irradiation 20%
• Highly Aggressive 20%
• Secondary Malignancy 20%
• Complete Response 20%
• Relative Resistance 20%
• Toxicity Profile 20%
• Germline TP53 mutation 20%
• High Efficacy 20%
• Relapsed Tumor 20%
• Proton 20%
• Neurological Diseases 20%
• High Linear Energy Transfer 20%
• Proton Irradiation 20%
• Field Carcinogenesis 20%
• Particle Therapy 20%
• MRI Morphometry 20%
• Multimodal Strategy 20%
• DNA-damaging 20%
• Cell Markers 20%
• Homologous Recombination Deficiency 20%
• Host Mice 20%

Medicine and Dentistry

• Chromothripsis 100%
• Medulloblastoma 100%
• Li Fraumeni 100%
• Ion Therapy 100%
• PARP Inhibitor 60%
• Tumor 40%
• Magnetic Resonance Imaging 40%
• Neurogenesis 40%
• Neoplasm 20%
• Cancer 20%
• Whole Genome Sequencing 20%
• Carcinogenesis 20%
• DNA Repair 20%
• Morphology 20%
• Cell Marker 20%
• Xenograft 20%
• Tumor Model 20%
• Photon Therapy 20%
• Li-Fraumeni Syndrome 20%
• Neurologic Disease 20%
• Topotecan 20%
• Intracranial Tumor 20%
• Homologous Recombination 20%
• Proton Irradiation 20%
• Particle Therapy 20%
• Linear Energy Transfer 20%
• Germ Cell 20%
• Chemotherapy 20%
• Histology 20%